 |
|
 |
Dr. Peter D. Adams, Ph.D., Institute for Cancer Research,
Fox Chase Cancer Center. Title of Project: Identification of novel
genetic mutations in breast cancer that predict a favorable clinical
response to the new anti-cancer therapeutic, SAHA. |
|
|
 |
Dr. Terry Van
Dyke, University of North
Carolina at Chapel Hill. Title of Project: A mouse model of human ovarian cancer for mechanistic, diagnostic and
therapeutic discovery. |
|
|
 |
Dr. William Carson, Ohio State University Research Foundation OSU Comprehensive Cancer Center. Title of Project: A Phase 1 Trial of IL-21 in Combination With Weekly Paclitaxel and Trastuzumab in Patients With HER2-Positive Malignancies. |
|
|
 |
Dr.
Brittney-Shea Herbert, Ph.D., Indiana University. Title
of Project: Targeting Telomerase
in Breast Cancer Stem Cells: Inhibition of Breast Tumor Recurrence
and Metastasis. |
|
|
 |
Dr. Maria
Jasin, Ph.D., Memorial
Sloan-Kettering Cancer Center. Title of Project: DNA repair defects
and ovarian cancer development. |
|
|
 |
Dr.
David Kurnit,
University of Michigan Medical Center. Title of
Project: Detection
of cervical dysplasia and cancer by MassARRAY detection of human papilloma
virus. |
|
|
 |
Dr. John
A. Martignetti, M.D., Ph.D., Mount Sinai School of Medicine,
Departments of Human Genetics and Oncological Sciences. Title
of Project: Inhibition of KLF6-SV1: Targeting Ovarian Cancer Spread
and Survival. |
|
|
 |
Dr.
Vered Stearns, M.D., Kimmel Cancer Center at Johns Hopkins. Title
of Project: Intraductal
therapy for breast cancer treatment and prevention. |
|
|
 |
Dr. Sheila A. Stewart, Washington University,
Department of Cell Biology & Physiology. Title
of Project: Stromal
Factors and Tumorigenesis. |
|
|
 |
Dr.
Theresa V. Strong, Ph.D., The University of Alabama at Birmingham. Title
of Project: The Role of Sp17 in Tumor Development. |
|
|
 |
Dr. Muneesh
Tewari, M.D., Ph.D.,
Fred Hutchinson Cancer Research Center. Title
of Project: An Integrated
Functional Genomic Approach to Identify Cisplatin Resistance Determinants
in Ovarian Cancer. |
|
|
 |
Dr.
Michael A. White, U.T. Southwestern Medical Center. Title
of Project: Harnessing
Genome-Wide RNAi to Guide Rational Design of Combinatorial Chemotherapies
Targeting Ovarian Cancer. |
|
|
 |
Dr. Hua Zhao, Ph.D., Tulane
University School of Public Health and Tropical Medicine. Title
of Project: Pharmocogenetic Profiles to Predict Response to Chemotherapy in Ovarian
Cancer. |
|
|
|